Table of Content


Chapter 1. Methodology
1.1. Methodology
1.2. Base estimates & working
1.3. Forecast calculations
1.4. Data validation
1.5. Data Sources
1.5.1. Secondary
1.5.1.1. Paid Sources
1.5.1.2. Unpaid Sources
1.5.2. Primary
Chapter 2. Executive Summary
2.1. Compounding pharmacies industry 360 degree synopsis, 2016 – 2027
2.1.1. Business trends
2.1.2. Therapeutic area trends
2.1.3. Product trends
2.1.4. Application trends
2.1.5. Compounding type trends
2.1.6. Sterility trends
2.1.7. Distribution channel trends
2.1.8. Regional trends
Chapter 3. Compounding Pharmacies Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2016 - 2027
3.3. Industry ecosystem analysis
3.3.1. Distribution channel analysis
3.4. Industry impact forces
3.4.1. Growth drivers
3.4.1.1. Rising geriatric population and improved life expectancy across the globe
3.4.1.2. Rising adoption of customized medicine in the developed regions
3.4.1.3. Shortage of drugs across the globe
3.4.1.4. Benefits of compounded medication
3.4.1.5. Growing drug failure rate
3.4.2. Industry pitfalls and challenges
3.4.2.1. Lack of skilled lab technicians and pharmacists in developed economies
3.4.2.2. High cost of equipment and maintenance of sterile environment
3.4.2.3. Volatile regulatory scenario
3.4.2.4. Consumer perception towards compounded drugs
3.5. Growth potential analysis
3.5.1. By therapeutic area
3.5.2. By product
3.5.3. By application
3.5.4. By compounding type
3.5.5. By sterility
3.5.6. By distribution channel
3.6. Regulatory landscape
3.6.1. U.S.
3.6.2. Europe
3.6.3. Australia
3.7. Reimbursement landscape
3.7.1. U.S.
3.7.2. Europe
3.7.3. Australia
3.8. Cost analysis of compounded medications
3.9. Compounding pharmacies count, by region 2019
3.9.1. North America
3.9.2. Europe
3.9.3. Asia Pacific
3.9.4. Latin America
3.9.5. Middle East and Africa
3.10. Innovative compounding technologies
3.10.1. Web-based quality management system
3.10.2. Digital tools
3.11. COVID-19 impact analysis
3.12. Porter’s analysis
3.13. Competitive landscape, 2020
3.13.1. Company matrix analysis, 2020
3.14. PESTEL Analysis
Chapter 4. Compounding Pharmacies Market, By Therapeutic Area
4.1. Key segment trends
4.2. Hormone replacement
4.2.1. Market size, by region, 2016 – 2027
4.3. Pain management
4.3.1. Market size, by region, 2016 – 2027
4.4. Dermatology
4.4.1. Market size, by region, 2016 – 2027
4.5. Specialty drugs
4.5.1. Market size, by region, 2016 – 2027
4.6. Nutritional supplements
4.6.1. Market size, by region, 2016 – 2027
4.7. Others
4.7.1. Market size, by region, 2016 – 2027
Chapter 5. Compounding Pharmacies Market, By Product
5.1. Key segment trends
5.2. Oral
5.2.1. Market size, by region, 2016 – 2027
5.2.1.1. Solid preparations
5.2.1.1.1. Market size, by region, 2016 – 2027
5.2.1.1.2. Tablets
5.2.1.1.2.1. Market size, by region, 2016 – 2027
5.2.1.1.3. Capsules
5.2.1.1.3.1. Market size, by region, 2016 – 2027
5.2.1.1.4. Granules
5.2.1.1.4.1. Market size, by region, 2016 – 2027
5.2.1.1.5. Powder
5.2.1.1.5.1. Market size, by region, 2016 – 2027
5.2.1.1.6. Others
5.2.1.1.6.1. Market size, by region, 2016 – 2027
5.2.1.2. Liquid preparations
5.2.1.3. Market size, by region, 2016 – 2027
5.2.1.3.1. Solutions
5.2.1.3.1.1. Market size, by region, 2016 – 2027
5.2.1.3.2. Suspension
5.2.1.3.2.1. Market size, by region, 2016 – 2027
5.2.1.3.3. Emulsion
5.2.1.3.3.1. Market size, by region, 2016 – 2027
5.2.1.3.4. Syrup
5.2.1.3.4.1. Market size, by region, 2016 – 2027
5.2.1.3.5. Others
5.2.1.3.5.1. Market size, by region, 2016 – 2027
5.3. Topical
5.3.1. Market size, by region, 2016 – 2027
5.3.2. Ointments
5.3.2.1. Market size, by region, 2016 – 2027
5.3.3. Creams
5.3.3.1. Market size, by region, 2016 – 2027
5.3.4. Gels
5.3.4.1. Market size, by region, 2016 – 2027
5.3.5. Pastes
5.3.5.1. Market size, by region, 2016 – 2027
5.3.6. Others
5.3.6.1. Market size, by region, 2016 – 2027
5.4. Rectal
5.4.1. Market size, by region, 2016 – 2027
5.4.2. Suppositories
5.4.2.1. Market size, by region, 2016 – 2027
5.4.3. Enema
5.4.3.1. Market size, by region, 2016 – 2027
5.4.4. Others
5.4.4.1. Market size, by region, 2016 – 2027
5.5. Parenteral
5.5.1. Market size, by region, 2016 – 2027
5.5.2. Small volume parenteral (SVP) solutions
5.5.2.1. Market size, by region, 2016 – 2027
5.5.3. Large volume parenteral (LVP) solutions
5.5.3.1. Market size, by region, 2016 – 2027
5.6. Nasal
5.6.1. Market size, by region, 2016 – 2027
5.7. Ophthalmic
5.7.1. Market size, by region, 2016 – 2027
5.8. Otic
5.8.1. Market size, by region, 2016 – 2027
Chapter 6. Compounding Pharmacies Market, By Application
6.1. Key segment trends
6.2. Paediatric
6.2.1. Market size, by region, 2016 – 2027
6.3. Adult
6.3.1. Market size, by region, 2016 – 2027
6.4. Geriatric
6.4.1. Market size, by region, 2016 – 2027
6.5. Veterinary
6.5.1. Market size, by region, 2016 – 2027
Chapter 7. Compounding Pharmacies Market, By Compounding Type
7.1. Key segment trends
7.2. Pharmaceutical Ingredient Alteration (PIA)
7.2.1. Market size, by region, 2016 – 2027
7.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
7.3.1. Market size, by region, 2016 – 2027
7.4. Pharmaceutical Dosage Alteration (PDA)
7.4.1. Market size, by region, 2016 – 2027
7.5. Others
7.5.1. Market size, by region, 2016 – 2027
Chapter 8. Compounding Pharmacies Market, By Sterility
8.1. Key segment trends
8.2. Sterile
8.2.1. Market size, by region, 2016 – 2027
8.3. Non-sterile
8.3.1. Market size, by region, 2016 – 2027
Chapter 9. Compounding Pharmacies Market, By Distribution Channel
9.1. Key segment trends
9.2. Hospital pharmacy
9.2.1. Market size, by region, 2016 – 2027
9.3. Compounding pharmacy
9.3.1. Market size, by region, 2016 – 2027
9.4. Others
9.4.1. Market size, by region, 2016 – 2027
Chapter 10. Compounding Pharmacies Market, By Region
10.1. Key regional trends
10.2. North America
10.2.1. Market size, by country, 2016 – 2027
10.2.2. Market size, by therapeutic area, 2016 – 2027
10.2.3. Market size, by product, 2016 – 2027
10.2.3.1. Market size, by oral, 2016 – 2027
10.2.3.1.1. Market size, by solid preparation, 2016 – 2027
10.2.3.1.2. Market size, by liquid preparation, 2016 – 2027
10.2.3.2. Market size, by topical, 2016 – 2027
10.2.3.3. Market size, by rectal, 2016 – 2027
10.2.3.4. Market size, by parenteral, 2016 – 2027
10.2.4. Market size, by application, 2016 – 2027
10.2.5. Market size, by compounding type, 2016 – 2027
10.2.6. Market size, by sterility, 2016 – 2027
10.2.7. Market size, by distributional channel, 2016 – 2027
10.2.8. U.S.
10.2.8.1. Market size, by therapeutic area, 2016 – 2027
10.2.8.2. Market size, by product, 2016 – 2027
10.2.8.2.1. Market size, by oral, 2016 – 2027
10.2.8.2.1.1. Market size, by solid preparation, 2016 – 2027
10.2.8.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.2.8.2.2. Market size, by topical, 2016 – 2027
10.2.8.2.3. Market size, by rectal, 2016 – 2027
10.2.8.2.4. Market size, by parenteral, 2016 – 2027
10.2.8.3. Market size, by application, 2016 – 2027
10.2.8.4. Market size, by compounding type, 2016 – 2027
10.2.8.5. Market size, by sterility, 2016 – 2027
10.2.8.6. Market size, by distribution channel, 2016 – 2027
10.2.9. Canada
10.2.9.1. Market size, by therapeutic area, 2016 – 2027
10.2.9.2. Market size, by product, 2016 – 2027
10.2.9.2.1. Market size, by oral, 2016 – 2027
10.2.9.2.1.1. Market size, by solid preparation, 2016 – 2027
10.2.9.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.2.9.2.2. Market size, by topical, 2016 – 2027
10.2.9.2.3. Market size, by rectal, 2016 – 2027
10.2.9.2.4. Market size, by parenteral, 2016 – 2027
10.2.9.3. Market size, by application, 2016 – 2027
10.2.9.4. Market size, by compounding type, 2016 – 2027
10.2.9.5. Market size, by sterility, 2016 – 2027
10.2.9.6. Market size, by distribution channel, 2016 – 2027
10.3. Europe
10.3.1. Market size, by country, 2016 – 2027
10.3.2. Market size, by therapeutic area, 2016 – 2027
10.3.3. Market size, by product, 2016 – 2027
10.3.3.1. Market size, by oral, 2016 – 2027
10.3.3.1.1. Market size, by solid preparation, 2016 – 2027
10.3.3.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.3.2. Market size, by topical, 2016 – 2027
10.3.3.3. Market size, by rectal, 2016 – 2027
10.3.3.4. Market size, by parenteral, 2016 – 2027
10.3.4. Market size, by application, 2016 – 2027
10.3.5. Market size, by compounding type, 2016 – 2027
10.3.6. Market size, by sterility, 2016 – 2027
10.3.7. Market size, by distributional channel, 2016 – 2027
10.3.8. Germany
10.3.8.1. Market size, by therapeutic area, 2016 – 2027
10.3.8.2. Market size, by product, 2016 – 2027
10.3.8.2.1. Market size, by oral, 2016 – 2027
10.3.8.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.8.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.8.2.2. Market size, by topical, 2016 – 2027
10.3.8.2.3. Market size, by rectal, 2016 – 2027
10.3.8.2.4. Market size, by parenteral, 2016 – 2027
10.3.8.3. Market size, by application, 2016 – 2027
10.3.8.4. Market size, by compounding type, 2016 – 2027
10.3.8.5. Market size, by sterility, 2016 – 2027
10.3.8.6. Market size, by distribution channel, 2016 – 2027
10.3.9. UK
10.3.9.1. Market size, by therapeutic area, 2016 – 2027
10.3.9.2. Market size, by product, 2016 – 2027
10.3.9.2.1. Market size, by oral, 2016 – 2027
10.3.9.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.9.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.9.2.2. Market size, by topical, 2016 – 2027
10.3.9.2.3. Market size, by rectal, 2016 – 2027
10.3.9.2.4. Market size, by parenteral, 2016 – 2027
10.3.9.3. Market size, by application, 2016 – 2027
10.3.9.4. Market size, by compounding type, 2016 – 2027
10.3.9.5. Market size, by sterility, 2016 – 2027
10.3.9.6. Market size, by distribution channel, 2016 – 2027
10.3.10. France
10.3.10.1. Market size, by therapeutic area, 2016 – 2027
10.3.10.2. Market size, by product, 2016 – 2027
10.3.10.2.1. Market size, by oral, 2016 – 2027
10.3.10.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.10.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.10.2.2. Market size, by topical, 2016 – 2027
10.3.10.2.3. Market size, by rectal, 2016 – 2027
10.3.10.2.4. Market size, by parenteral, 2016 – 2027
10.3.10.3. Market size, by application, 2016 – 2027
10.3.10.4. Market size, by compounding type, 2016 – 2027
10.3.10.5. Market size, by sterility, 2016 – 2027
10.3.10.6. Market size, by distribution channel, 2016 – 2027
10.3.11. Italy
10.3.11.1. Market size, by therapeutic area, 2016 – 2027
10.3.11.2. Market size, by product, 2016 – 2027
10.3.11.2.1. Market size, by oral, 2016 – 2027
10.3.11.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.11.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.11.2.2. Market size, by topical, 2016 – 2027
10.3.11.2.3. Market size, by rectal, 2016 – 2027
10.3.11.2.4. Market size, by parenteral, 2016 – 2027
10.3.11.3. Market size, by application, 2016 – 2027
10.3.11.4. Market size, by compounding type, 2016 – 2027
10.3.11.5. Market size, by sterility, 2016 – 2027
10.3.11.6. Market size, by distribution channel, 2016 – 2027
10.3.12. Spain
10.3.12.1. Market size, by therapeutic area, 2016 – 2027
10.3.12.2. Market size, by product, 2016 – 2027
10.3.12.2.1. Market size, by oral, 2016 – 2027
10.3.12.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.12.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.12.2.2. Market size, by topical, 2016 – 2027
10.3.12.2.3. Market size, by rectal, 2016 – 2027
10.3.12.2.4. Market size, by parenteral, 2016 – 2027
10.3.12.3. Market size, by application, 2016 – 2027
10.3.12.4. Market size, by compounding type, 2016 – 2027
10.3.12.5. Market size, by sterility, 2016 – 2027
10.3.12.6. Market size, by distribution channel, 2016 – 2027
10.3.13. Poland
10.3.13.1. Market size, by therapeutic area, 2016 – 2027
10.3.13.2. Market size, by product, 2016 – 2027
10.3.13.2.1. Market size, by oral, 2016 – 2027
10.3.13.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.13.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.13.2.2. Market size, by topical, 2016 – 2027
10.3.13.2.3. Market size, by rectal, 2016 – 2027
10.3.13.2.4. Market size, by parenteral, 2016 – 2027
10.3.13.3. Market size, by application, 2016 – 2027
10.3.13.4. Market size, by compounding type, 2016 – 2027
10.3.13.5. Market size, by sterility, 2016 – 2027
10.3.13.6. Market size, by distribution channel, 2016 – 2027
10.3.14. Ukraine
10.3.14.1. Market size, by therapeutic area, 2016 – 2027
10.3.14.2. Market size, by product, 2016 – 2027
10.3.14.2.1. Market size, by oral, 2016 – 2027
10.3.14.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.14.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.14.2.2. Market size, by topical, 2016 – 2027
10.3.14.2.3. Market size, by rectal, 2016 – 2027
10.3.14.2.4. Market size, by parenteral, 2016 – 2027
10.3.14.3. Market size, by application, 2016 – 2027
10.3.14.4. Market size, by compounding type, 2016 – 2027
10.3.14.5. Market size, by sterility, 2016 – 2027
10.3.14.6. Market size, by distribution channel, 2016 – 2027
10.3.15. Greece
10.3.15.1. Market size, by therapeutic area, 2016 – 2027
10.3.15.2. Market size, by product, 2016 – 2027
10.3.15.2.1. Market size, by oral, 2016 – 2027
10.3.15.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.15.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.15.2.2. Market size, by topical, 2016 – 2027
10.3.15.2.3. Market size, by rectal, 2016 – 2027
10.3.15.2.4. Market size, by parenteral, 2016 – 2027
10.3.15.3. Market size, by application, 2016 – 2027
10.3.15.4. Market size, by compounding type, 2016 – 2027
10.3.15.5. Market size, by sterility, 2016 – 2027
10.3.15.6. Market size, by distribution channel, 2016 – 2027
10.3.16. Sweden
10.3.16.1. Market size, by therapeutic area, 2016 – 2027
10.3.16.2. Market size, by product, 2016 – 2027
10.3.16.2.1. Market size, by oral, 2016 – 2027
10.3.16.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.16.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.16.2.2. Market size, by topical, 2016 – 2027
10.3.16.2.3. Market size, by rectal, 2016 – 2027
10.3.16.2.4. Market size, by parenteral, 2016 – 2027
10.3.16.3. Market size, by application, 2016 – 2027
10.3.16.4. Market size, by compounding type, 2016 – 2027
10.3.16.5. Market size, by sterility, 2016 – 2027
10.3.16.6. Market size, by distribution channel, 2016 – 2027
10.3.17. Norway
10.3.17.1. Market size, by therapeutic area, 2016 – 2027
10.3.17.2. Market size, by product, 2016 – 2027
10.3.17.2.1. Market size, by oral, 2016 – 2027
10.3.17.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.17.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.17.2.2. Market size, by topical, 2016 – 2027
10.3.17.2.3. Market size, by rectal, 2016 – 2027
10.3.17.2.4. Market size, by parenteral, 2016 – 2027
10.3.17.3. Market size, by application, 2016 – 2027
10.3.17.4. Market size, by compounding type, 2016 – 2027
10.3.17.5. Market size, by sterility, 2016 – 2027
10.3.17.6. Market size, by distribution channel, 2016 – 2027
10.3.18. Belgium
10.3.18.1. Market size, by therapeutic area, 2016 – 2027
10.3.18.2. Market size, by product, 2016 – 2027
10.3.18.2.1. Market size, by oral, 2016 – 2027
10.3.18.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.18.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.18.2.2. Market size, by topical, 2016 – 2027
10.3.18.2.3. Market size, by rectal, 2016 – 2027
10.3.18.2.4. Market size, by parenteral, 2016 – 2027
10.3.18.3. Market size, by application, 2016 – 2027
10.3.18.4. Market size, by compounding type, 2016 – 2027
10.3.18.5. Market size, by sterility, 2016 – 2027
10.3.18.6. Market size, by distribution channel, 2016 – 2027
10.3.19. Czech Republic
10.3.19.1. Market size, by therapeutic area, 2016 – 2027
10.3.19.2. Market size, by product, 2016 – 2027
10.3.19.2.1. Market size, by oral, 2016 – 2027
10.3.19.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.19.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.19.2.2. Market size, by topical, 2016 – 2027
10.3.19.2.3. Market size, by rectal, 2016 – 2027
10.3.19.2.4. Market size, by parenteral, 2016 – 2027
10.3.19.3. Market size, by application, 2016 – 2027
10.3.19.4. Market size, by compounding type, 2016 – 2027
10.3.19.5. Market size, by sterility, 2016 – 2027
10.3.19.6. Market size, by distribution channel, 2016 – 2027
10.3.20. Finland
10.3.20.1. Market size, by therapeutic area, 2016 – 2027
10.3.20.2. Market size, by product, 2016 – 2027
10.3.20.2.1. Market size, by oral, 2016 – 2027
10.3.20.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.20.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.20.2.2. Market size, by topical, 2016 – 2027
10.3.20.2.3. Market size, by rectal, 2016 – 2027
10.3.20.2.4. Market size, by parenteral, 2016 – 2027
10.3.20.3. Market size, by application, 2016 – 2027
10.3.20.4. Market size, by compounding type, 2016 – 2027
10.3.20.5. Market size, by sterility, 2016 – 2027
10.3.20.6. Market size, by distribution channel, 2016 – 2027
10.3.21. Russia
10.3.21.1. Market size, by therapeutic area, 2016 – 2027
10.3.21.2. Market size, by product, 2016 – 2027
10.3.21.2.1. Market size, by oral, 2016 – 2027
10.3.21.2.1.1. Market size, by solid preparation, 2016 – 2027
10.3.21.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.3.21.2.2. Market size, by topical, 2016 – 2027
10.3.21.2.3. Market size, by rectal, 2016 – 2027
10.3.21.2.4. Market size, by parenteral, 2016 – 2027
10.3.21.3. Market size, by application, 2016 – 2027
10.3.21.4. Market size, by compounding type, 2016 – 2027
10.3.21.5. Market size, by sterility, 2016 – 2027
10.3.21.6. Market size, by distribution channel, 2016 – 2027
10.4. Asia Pacific
10.4.1. Market size, by country, 2016 – 2027
10.4.2. Market size, by therapeutic area, 2016 – 2027
10.4.3. Market size, by product, 2016 – 2027
10.4.3.1. Market size, by oral, 2016 – 2027
10.4.3.1.1. Market size, by solid preparation, 2016 – 2027
10.4.3.1.2. Market size, by liquid preparation, 2016 – 2027
10.4.3.2. Market size, by topical, 2016 – 2027
10.4.3.3. Market size, by rectal, 2016 – 2027
10.4.3.4. Market size, by parenteral, 2016 – 2027
10.4.4. Market size, by application, 2016 – 2027
10.4.5. Market size, by compounding type, 2016 – 2027
10.4.6. Market size, by sterility, 2016 – 2027
10.4.7. Market size, by distributional channel, 2016 – 2027
10.4.8. Japan
10.4.8.1. Market size, by therapeutic area, 2016 – 2027
10.4.8.2. Market size, by product, 2016 – 2027
10.4.8.2.1. Market size, by oral, 2016 – 2027
10.4.8.2.1.1. Market size, by solid preparation, 2016 – 2027
10.4.8.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.4.8.2.2. Market size, by topical, 2016 – 2027
10.4.8.2.3. Market size, by rectal, 2016 – 2027
10.4.8.2.4. Market size, by parenteral, 2016 – 2027
10.4.8.3. Market size, by application, 2016 – 2027
10.4.8.4. Market size, by compounding type, 2016 – 2027
10.4.8.5. Market size, by sterility, 2016 – 2027
10.4.8.6. Market size, by distribution channel, 2016 – 2027
10.4.9. China
10.4.9.1. Market size, by therapeutic area, 2016 – 2027
10.4.9.2. Market size, by product, 2016 – 2027
10.4.9.2.1. Market size, by oral, 2016 – 2027
10.4.9.2.1.1. Market size, by solid preparation, 2016 – 2027
10.4.9.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.4.9.2.2. Market size, by topical, 2016 – 2027
10.4.9.2.3. Market size, by rectal, 2016 – 2027
10.4.9.2.4. Market size, by parenteral, 2016 – 2027
10.4.9.3. Market size, by application, 2016 – 2027
10.4.9.4. Market size, by compounding type, 2016 – 2027
10.4.9.5. Market size, by sterility, 2016 – 2027
10.4.9.6. Market size, by distribution channel, 2016 – 2027
10.4.10. India
10.4.10.1. Market size, by therapeutic area, 2016 – 2027
10.4.10.2. Market size, by product, 2016 – 2027
10.4.10.2.1. Market size, by oral, 2016 – 2027
10.4.10.2.1.1. Market size, by solid preparation, 2016 – 2027
10.4.10.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.4.10.2.2. Market size, by topical, 2016 – 2027
10.4.10.2.3. Market size, by rectal, 2016 – 2027
10.4.10.2.4. Market size, by parenteral, 2016 – 2027
10.4.10.3. Market size, by application, 2016 – 2027
10.4.10.4. Market size, by compounding type, 2016 – 2027
10.4.10.5. Market size, by sterility, 2016 – 2027
10.4.10.6. Market size, by distribution channel, 2016 – 2027
10.4.11. Singapore
10.4.11.1. Market size, by therapeutic area, 2016 – 2027
10.4.11.2. Market size, by product, 2016 – 2027
10.4.11.2.1. Market size, by oral, 2016 – 2027
10.4.11.2.1.1. Market size, by solid preparation, 2016 – 2027
10.4.11.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.4.11.2.2. Market size, by topical, 2016 – 2027
10.4.11.2.3. Market size, by rectal, 2016 – 2027
10.4.11.2.4. Market size, by parenteral, 2016 – 2027
10.4.11.3. Market size, by application, 2016 – 2027
10.4.11.4. Market size, by compounding type, 2016 – 2027
10.4.11.5. Market size, by sterility, 2016 – 2027
10.4.11.6. Market size, by distribution channel, 2016 – 2027
10.4.12. Australia
10.4.12.1. Market size, by therapeutic area, 2016 – 2027
10.4.12.2. Market size, by product, 2016 – 2027
10.4.12.2.1. Market size, by oral, 2016 – 2027
10.4.12.2.1.1. Market size, by solid preparation, 2016 – 2027
10.4.12.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.4.12.2.2. Market size, by topical, 2016 – 2027
10.4.12.2.3. Market size, by rectal, 2016 – 2027
10.4.12.2.4. Market size, by parenteral, 2016 – 2027
10.4.12.3. Market size, by application, 2016 – 2027
10.4.12.4. Market size, by compounding type, 2016 – 2027
10.4.12.5. Market size, by sterility, 2016 – 2027
10.4.12.6. Market size, by distribution channel, 2016 – 2027
10.5. Latin America
10.5.1. Market size, by country, 2016 – 2027
10.5.2. Market size, by therapeutic area, 2016 – 2027
10.5.3. Market size, by product, 2016 – 2027
10.5.3.1. Market size, by oral, 2016 – 2027
10.5.3.1.1. Market size, by solid preparation, 2016 – 2027
10.5.3.1.2. Market size, by liquid preparation, 2016 – 2027
10.5.3.2. Market size, by topical, 2016 – 2027
10.5.3.3. Market size, by rectal, 2016 – 2027
10.5.3.4. Market size, by parenteral, 2016 – 2027
10.5.4. Market size, by application, 2016 – 2027
10.5.5. Market size, by compounding type, 2016 – 2027
10.5.6. Market size, by sterility, 2016 – 2027
10.5.7. Market size, by distributional channel, 2016 – 2027
10.5.8. Brazil
10.5.8.1. Market size, by therapeutic area, 2016 – 2027
10.5.8.2. Market size, by product, 2016 – 2027
10.5.8.2.1. Market size, by oral, 2016 – 2027
10.5.8.2.1.1. Market size, by solid preparation, 2016 – 2027
10.5.8.2.1.2. Market size, by liquid preparation, 2016 – 2027
10.5.8.2.2. Market size, by topical, 2016 – 2027
10.5.8.2.3. Market size, by rectal, 2016 – 2027
10.5.8.2.4. Market size, by parenteral, 2016 – 2027
10.5.8.3. Market size, by application, 2016 – 2027
10.5.8.4. Market size, by compounding type, 2016 – 2027
10.5.8.5. Market size, by sterility, 2016 – 2027
10.5.8.6. Market size, by distribution channel, 2016 – 2027
10.5.9. Mexico
10.5.9.1. Market size, by therapeutic area, 2016 – 2027
10.5.9.2. Market size, by product, 2016 – 2027
10.5.9.2.1. Market size, by oral, 2016 – 2027
10.5.9.2.1.1. Market size, by solid preparation, 2016 – 2027
10.5.9.2.1.2. Market size, by liquid preparation, 2016 –